Kong et al. BMC Medicine 2014, 12:76 http://www.biomedcentral.com/1741-7015/12/76

RESEARCH ARTICLE

Open Access

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes Alice PS Kong1†, Xilin Yang1,2†, Wing-Yee So1, Andrea Luk1, Ronald CW Ma1, Risa Ozaki1, Kitty KT Cheung1, Heung-Man Lee1,3,4, Linda Yu5, Gang Xu1,3, Chun-Chung Chow1 and Juliana CN Chan1,3,4*

Abstract Background: Hyperglycemia is associated with increased risk of all-site cancer that may be mediated through activation of the renin-angiotensin-system (RAS) and 3-hydroxy-3-methyl-glutaryl-coenzyme-A-reductase (HMGCR) pathways. We examined the joint associations of optimal glycemic control (HbA1c

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.

Hyperglycemia is associated with increased risk of all-site cancer that may be mediated through activation of the renin-angiotensin-system (RAS) and 3...
378KB Sizes 0 Downloads 3 Views